Your browser doesn't support javascript.
loading
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization.
Planas, Delphine; Saunders, Nell; Maes, Piet; Guivel-Benhassine, Florence; Planchais, Cyril; Buchrieser, Julian; Bolland, William-Henry; Porrot, Françoise; Staropoli, Isabelle; Lemoine, Frederic; Péré, Hélène; Veyer, David; Puech, Julien; Rodary, Julien; Baele, Guy; Dellicour, Simon; Raymenants, Joren; Gorissen, Sarah; Geenen, Caspar; Vanmechelen, Bert; Wawina-Bokalanga, Tony; Martí-Carreras, Joan; Cuypers, Lize; Sève, Aymeric; Hocqueloux, Laurent; Prazuck, Thierry; Rey, Félix A; Simon-Loriere, Etienne; Bruel, Timothée; Mouquet, Hugo; André, Emmanuel; Schwartz, Olivier.
Afiliação
  • Planas D; Virus and Immunity Unit, Institut Pasteur, Université de Paris, CNRS UMR3569, Paris, France.
  • Saunders N; Vaccine Research Institute, Créteil, France.
  • Maes P; Virus and Immunity Unit, Institut Pasteur, Université de Paris, CNRS UMR3569, Paris, France.
  • Guivel-Benhassine F; École Doctorale BioSPC 562, Université de Paris, Paris, France.
  • Planchais C; Department of Microbiology, Laboratory of Clinical and Epidemiological Virology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.
  • Buchrieser J; Virus and Immunity Unit, Institut Pasteur, Université de Paris, CNRS UMR3569, Paris, France.
  • Bolland WH; Humoral Immunology Laboratory, Institut Pasteur, Université de Paris, INSERM U1222, Paris, France.
  • Porrot F; Virus and Immunity Unit, Institut Pasteur, Université de Paris, CNRS UMR3569, Paris, France.
  • Staropoli I; Virus and Immunity Unit, Institut Pasteur, Université de Paris, CNRS UMR3569, Paris, France.
  • Lemoine F; École Doctorale BioSPC 562, Université de Paris, Paris, France.
  • Péré H; Virus and Immunity Unit, Institut Pasteur, Université de Paris, CNRS UMR3569, Paris, France.
  • Veyer D; Virus and Immunity Unit, Institut Pasteur, Université de Paris, CNRS UMR3569, Paris, France.
  • Puech J; Hub de Bioinformatique et Biostatistique, Institut Pasteur, Université de Paris, CNRS USR 3756, Paris, France.
  • Rodary J; Laboratoire de Virologie, Service de Microbiologie, Hôpital Européen Georges Pompidou, Paris, France.
  • Baele G; Functional Genomics of Solid Tumors (FunGeST), Centre de Recherche des Cordelier, INSERM, Université de Paris, Sorbonne Université, Paris, France.
  • Dellicour S; Laboratoire de Virologie, Service de Microbiologie, Hôpital Européen Georges Pompidou, Paris, France.
  • Raymenants J; Functional Genomics of Solid Tumors (FunGeST), Centre de Recherche des Cordelier, INSERM, Université de Paris, Sorbonne Université, Paris, France.
  • Gorissen S; Laboratoire de Virologie, Service de Microbiologie, Hôpital Européen Georges Pompidou, Paris, France.
  • Geenen C; Laboratoire de Virologie, Service de Microbiologie, Hôpital Européen Georges Pompidou, Paris, France.
  • Vanmechelen B; Department of Microbiology, Laboratory of Clinical and Epidemiological Virology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.
  • Wawina-Bokalanga T; Department of Microbiology, Laboratory of Clinical and Epidemiological Virology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.
  • Martí-Carreras J; Spatial Epidemiology Lab (SpELL), Université Libre de Bruxelles, Brussels, Belgium.
  • Cuypers L; Laboratory of Clinical Microbiology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
  • Sève A; Laboratory of Clinical Microbiology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
  • Hocqueloux L; Laboratory of Clinical Microbiology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
  • Prazuck T; Department of Microbiology, Laboratory of Clinical and Epidemiological Virology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.
  • Rey FA; Department of Microbiology, Laboratory of Clinical and Epidemiological Virology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.
  • Simon-Loriere E; Department of Microbiology, Laboratory of Clinical and Epidemiological Virology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.
  • Bruel T; Department of Laboratory Medicine, National Reference Centre for Respiratory Pathogens, University Hospitals Leuven, Leuven, Belgium.
  • Mouquet H; Service de Maladies Infectieuses, CHR d'Orléans, Orléans, France.
  • André E; Service de Maladies Infectieuses, CHR d'Orléans, Orléans, France.
  • Schwartz O; Service de Maladies Infectieuses, CHR d'Orléans, Orléans, France.
Nature ; 602(7898): 671-675, 2022 02.
Article em En | MEDLINE | ID: mdl-35016199
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Imunização Secundária / Anticorpos Neutralizantes / Evasão da Resposta Imune / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Limite: Adult / Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Nature Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Imunização Secundária / Anticorpos Neutralizantes / Evasão da Resposta Imune / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Limite: Adult / Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Nature Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França